BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33545285)

  • 1. Real-time release testing of dissolution based on surrogate models developed by machine learning algorithms using NIR spectra, compression force and particle size distribution as input data.
    Galata DL; Könyves Z; Nagy B; Novák M; Mészáros LA; Szabó E; Farkas A; Marosi G; Nagy ZK
    Int J Pharm; 2021 Mar; 597():120338. PubMed ID: 33545285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raman-based real-time dissolution prediction using a deterministic permeation model.
    Horkovics-Kovats S; László Galata D; Zlatoš P; Nagy B; Alexandra Mészáros L; Kristóf Nagy Z
    Int J Pharm; 2022 Apr; 617():121624. PubMed ID: 35231548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raman mapping-based non-destructive dissolution prediction of sustained-release tablets.
    Galata DL; Zsiros B; Mészáros LA; Nagy B; Szabó E; Farkas A; Nagy ZK
    J Pharm Biomed Anal; 2022 Apr; 212():114661. PubMed ID: 35180565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fast, Spectroscopy-Based Prediction of In Vitro Dissolution Profile of Extended Release Tablets Using Artificial Neural Networks.
    Galata DL; Farkas A; Könyves Z; Mészáros LA; Szabó E; Csontos I; Pálos A; Marosi G; Nagy ZK; Nagy B
    Pharmaceutics; 2019 Aug; 11(8):. PubMed ID: 31405029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Convolutional neural network-based evaluation of chemical maps obtained by fast Raman imaging for prediction of tablet dissolution profiles.
    Galata DL; Zsiros B; Knyihár G; Péterfi O; Mészáros LA; Ronkay F; Nagy B; Szabó E; Nagy ZK; Farkas A
    Int J Pharm; 2023 Jun; 640():123001. PubMed ID: 37254287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of artificial neural networks for Process Analytical Technology-based dissolution testing.
    Nagy B; Petra D; Galata DL; Démuth B; Borbás E; Marosi G; Nagy ZK; Farkas A
    Int J Pharm; 2019 Aug; 567():118464. PubMed ID: 31252145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug release-modulating mechanism of hydrophilic hydroxypropylmethylcellulose matrix tablets: distribution of atoms and carrier and texture analysis.
    Park JB; Lim J; Kang CY; Lee BJ
    Curr Drug Deliv; 2013 Dec; 10(6):732-41. PubMed ID: 23855499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of hydroxypropyl methylcellulose mixture, apparent viscosity, and tablet hardness on drug release using a 2(3) full factorial design.
    Khanvilkar KH; Huang Y; Moore AD
    Drug Dev Ind Pharm; 2002 May; 28(5):601-8. PubMed ID: 12098849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of manufacturing process variables on in vitro dissolution characteristics of extended-release tablets formulated with hydroxypropyl methylcellulose.
    Huang Y; Khanvilkar KH; Moore AD; Hilliard-Lott M
    Drug Dev Ind Pharm; 2003 Jan; 29(1):79-88. PubMed ID: 12602495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing the Performance of Raman and Near-Infrared Imaging in the Prediction of the In Vitro Dissolution Profile of Extended-Release Tablets Based on Artificial Neural Networks.
    Galata DL; Gergely S; Nagy R; Slezsák J; Ronkay F; Nagy ZK; Farkas A
    Pharmaceuticals (Basel); 2023 Sep; 16(9):. PubMed ID: 37765051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of drug:hydroxypropylmethylcellulose ratio, drug and polymer particle size and compression force on the release of diclofenac sodium from HPMC tablets.
    Velasco MV; Ford JL; Rowe P; Rajabi-Siahboomi AR
    J Control Release; 1999 Jan; 57(1):75-85. PubMed ID: 9863041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral controlled release formulations of rifampicin. Part II: Effect of formulation variables and process parameters on in vitro release.
    Hiremath PS; Saha RN
    Drug Deliv; 2008; 15(3):159-68. PubMed ID: 18379928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of hypromellose particle size effects on drug release from sustained release hydrophilic matrix tablets.
    Mitchell SA; Balwinski KM
    Drug Dev Ind Pharm; 2007 Sep; 33(9):952-8. PubMed ID: 17891581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The performance of HPMC matrix tablets using various agglomeration manufacturing processes.
    Košir D; Vrečer F
    Drug Dev Ind Pharm; 2017 Feb; 43(2):329-337. PubMed ID: 27739880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of water penetration and drug concentration profiles in HPMC-based matrix tablets by near infrared chemical imaging.
    Li W; Woldu A; Araba L; Winstead D
    J Pharm Sci; 2010 Jul; 99(7):3081-8. PubMed ID: 20112431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of Within-Tablet Dynamics for Extended Release of a Poorly Soluble Basic Drug from Hydrophilic Matrix Tablets Using ATR-FTIR Imaging.
    Zahoor FD; Mader KT; Timmins P; Brown J; Sammon C
    Mol Pharm; 2020 Apr; 17(4):1090-1099. PubMed ID: 32069060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of physicochemical properties of hydroxypropyl methylcellulose (HPMC) type 2208 and their influence on prolonged drug release from matrix tablets.
    Devjak Novak S; Šporar E; Baumgartner S; Vrečer F
    J Pharm Biomed Anal; 2012 Jul; 66():136-43. PubMed ID: 22510313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Release of poorly soluble drugs from HPMC tablets studied by FTIR imaging and flow-through dissolution tests.
    van der Weerd J; Kazarian SG
    J Pharm Sci; 2005 Sep; 94(9):2096-109. PubMed ID: 16052556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3D printing of extended-release tablets of theophylline using hydroxypropyl methylcellulose (HPMC) hydrogels.
    Cheng Y; Qin H; Acevedo NC; Jiang X; Shi X
    Int J Pharm; 2020 Dec; 591():119983. PubMed ID: 33065220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enabling real time release testing by NIR prediction of dissolution of tablets made by continuous direct compression (CDC).
    Pawar P; Wang Y; Keyvan G; Callegari G; Cuitino A; Muzzio F
    Int J Pharm; 2016 Oct; 512(1):96-107. PubMed ID: 27543350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.